Meeting Banner
Abstract #3746

How does Levodopa treatment in Parkinson’s disease impact perfusion: A MR pCASL Study

Hanyu Wei1,2, Le He1, Rui Li1, and Yu Ma3
1Tsinghua University, Beijing, China, 2Tsinghua University, Bejing, China, 3Department of Neurosurgery, Tsinghua University Yuquan Hospital, Beijing, China

Synopsis

Levodopa therapy of Parkinson’s disease(PD) was considered to have effects on dopamine and norepinephrine levels therefore tending to alter the cardiovascular circulation. To find how cerebral perfusion changes in the levodopa process among PD patients, both perfusion capacity and spatial patterns computations were performed in this study. The initial conclusion is no obvious evidence supporting that cerebral perfusion alternation was effected in levodopa process. Further investigations were required to validate this point of view.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords